18. January 2025 Pipeline The recent published results of the ISAT-2 study draw a different view on the future of open microsurgical intervention for aSAH and on the therapeutic implications of its treatment with NicaPlant
20. August 2024 Pipeline BIT Pharma announces the publication of an original investigation with the results of a randomized clinical trial with NicaPlant (Nicardipine Release Implants) for the prevention of vasospasm after Aneurysmal Subarachnoid Hemorrhage in JAMA Neurology.
22. May 2023 Pipeline Phase 2 data with NicaPlant ® in aneurysmal subarachnoid haemorrhage patients will be presented at the XXVI Congress of Spanish Society of Neurosurgery (SENEC)
14. December 2022 Company Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia
29. October 2022 Company ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant
19. October 2022 Pipeline European Medicines Agency Grants PRIME Designation to BIT Pharma’s NicaPlant® for Treatment of Non-traumatic Subarachnoid Haemorrhage in Patients undergoing Surgery.
31. August 2022 Pipeline BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences
1. July 2022 Pipeline BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in Aneurysmal Subarachnoid Heamorrhage patients (aSAH) undergoing aneurysm clipping.
